← Back to all trials
Active Not Recruiting
NCT04982393
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Conditions: Primary Hyperoxaluria Type 1
Sex: All
Healthy volunteers: No
Enrollment: 207
Sponsor: Alnylam Pharmaceuticals
Location: Clinical Trial Site Phoenix Arizona
Summary
The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness of lumasiran.
Eligibility Criteria
Inclusion Criteria:
* Documented diagnosis of PH1, per physician's determination
Exclusion Criteria:
* Currently enrolled in a clinical trial for any investigational agent
Source: ClinicalTrials.gov (NCT04982393). StuddyBuddy aggregates publicly available trial information.
